Journal of substance use and addiction treatment
June 1, 2023
Angela M Haeny, Joel A Lopez, Pamela A Colón Grigas et al.
10 citations
Among 211 racially and ethnically minoritized (REM) adults in the US and Canada, retrospective reports indicated that after their most memorable psychedelic experience, alcohol use and drug use were perceived to have decreased. The reduction in alcohol use was greater for Indigenous participants, those who took a high dose, those with a stronger ethnic identity, and those who reported fewer depressive symptoms. Perceived increases in psychological flexibility and reductions in racial trauma symptoms appeared to mediate the link between acute psychedelic effects and reduced substance use. The authors suggest psychedelic experiences may help REM people reduce alcohol and drug use by increasing psychological flexibility and easing racial trauma, but call for longitudinal replication.
International Journal of Mental Health and Addiction
April 1, 2024
Doris Payer, Sukhpreet Klaire, Dominique Morisano et al.
4 citations
A 2022 scientific research conference in Toronto brought together stakeholders from multiple disciplines to discuss the potential role of psychedelic compounds in treating mental health and substance use disorders. This Special Issue includes 8 papers based on conference presentations, covering quantitative and qualitative works plus two letters to the editors. The articles present the current state of psychedelic research, viewpoints on impacts for underrepresented communities, the need to recognize the history of these compounds beyond the new Western renaissance, and the complexities of integrating psychedelics into mainstream medicine. The collection emphasizes that collaboration can advance the field to harness its potential impact.
Current oncology (Toronto, Ont.)
December 22, 2025
Linda E Carlson, Harriet Richardson, Ron Shore et al.
1 citation
The CAnadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT), launched in 2025, aims to address demoralization syndrome and psychosocial distress in Canadians with cancer. The network has six objectives: building a national interdisciplinary network, setting research priorities through stakeholder engagement, developing training for clinicians and researchers, pilot-testing intervention procedures, conducting a multi-center randomized controlled trial of psychedelic-assisted therapy (PAT) for advanced cancer, and informing healthcare policy. CAN-PACT seeks to generate Canadian evidence and prepare the oncology system for equitable access to safe, evidence-based PAT in publicly funded cancer centers.